SCHEMBL14399367

SCHEMBL14399367

CC(CCc1ccccc1)NC(=O)Cc1ccc(Br)cc1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.74
KMT2A Q03164 6/20 0.70
HSP90AA1 P07900 1/20 0.69
POLB P06746 3/20 0.65
CNR2 P34972 2/20 0.60
HPGD P15428 2/20 0.59
HTT P42858 2/20 0.59
SMN1; SMN2 Q16637 2/20 0.59
MEN1 O00255 4/20 0.57
ESR1 P03372 1/20 0.55
ESR2 Q92731 1/20 0.55
L3MBTL1 Q9Y468 1/20 0.55
CYP1A2 P05177 1/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6297588 0.91 ALDH1A1 (0.81) ALDH1A1KMT2APOLBCNR2HPGD
SCHEMBL14399184 0.87 ALDH1A1 (0.76) ALDH1A1KMT2APOLBCNR2HPGD
SCHEMBL5325371 0.87 ALDH1A1 (0.76) ALDH1A1KMT2APOLBCNR2HPGD
SCHEMBL5325429 0.87 ALDH1A1 (0.76) ALDH1A1KMT2APOLBCNR2HPGD
SCHEMBL5327587 0.86 ALDH1A1 (0.74) ALDH1A1KMT2APOLBCNR2HPGD
SCHEMBL14399186 0.86 ALDH1A1 (0.74) ALDH1A1KMT2APOLBCNR2HPGD
SCHEMBL14399009 0.86 ALDH1A1 (0.74) ALDH1A1KMT2APOLBCNR2HPGD
SCHEMBL5330709 0.85 ALDH1A1 (0.81) ALDH1A1KMT2APOLBCNR2HPGD
SCHEMBL5323930 0.84 ALDH1A1 (0.70) ALDH1A1KMT2APOLBCNR2HPGD
SCHEMBL5325778 0.84 KMT2A (0.76) ALDH1A1KMT2APOLBCNR2HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2007120083-A1 THE USE OF CARBOXAMIDE DERIVATIVES IN THE MANUFACTURE OF A MEDICAMENT FOR THE TREATMENT OF INFLAMMATORY, ALLERGIC AND DERMATOLOGICAL CONDITIONS ASTRAZENECA AB (SE) 2007-10-25 WO disclosed